On May 23, 2023, Shengshi Baicao 2023 Origin Cooperation Conference was held in Xi 'an.

 

Japan's Jincun Pharmaceutical Department's head of Pingshou Haosi, head of the Pharmaceutical Production and Management Department of Chiyama and other history, cultivation technology development department minister Shenbao Zhiichi, section chief Kumazawa Hiroaki, head of the Pharmaceutical Business Department Neng Yoshiaki, section chief Shintaro Kimura, Long Sheng Guizhi and other leaders attended the meeting in person and through online.

 

Li Gang, General Manager of Ping An Jincun Pharmaceutical, Shenzhen Jincun and Shengshi Baicao, Yichun Watanabe, Deputy General Manager of Ping An Jincun Pharmaceutical, Executive Deputy General Manager of Shenzhen Jincun and Deputy General Manager of Shengshi Baicao, Chen Yanguo, Deputy General Manager of Ping An Jincun Pharmaceutical and Executive Deputy General Manager of Shengshi Baicao, and Chunyan Takahashi, Financial Director of Ping An Jincun, attended the meeting in person.

 

Also present at the meeting were Yao Ling, deputy general manager of Shenzhen Jincun, Li Shiyu, minister of planting management, Li Lianguo, minister of business, Fuda Wuzhi and Xiao Pingkuo, leaders and colleagues of planting management, business and Pingcun Medicine.

 

Cao Lijuan and Liu Tianzhi, deputy general managers of Shengshi Baicao, leaders and colleagues of purchasing department, planting management department, business department, quality management department, production department and sales department, as well as representatives of dozens of domestic production companies attended the meeting.

 

---

 

▲ Liu Tianzhi, Deputy General Manager of Shengshi Baicao, delivered a welcome speech

 

Liu Tianzhi, deputy general manager of Shengshi Baicao, first extended a warm welcome to the leaders and representatives of various producing areas, and made a report on Shengshi Baicao's business performance, phase III construction and future goals.

 

Liu Zong pointed out that in 2022, in the face of the pressure brought by the epidemic, all employees of the company and the producing areas will not flinch. Under the correct leadership of General Manager Li Gang and with the full support of Japan's Jincun, Shanghai Jincun, Shenzhen Jincun and the producing areas, Shengshi Baicao successfully completed its annual task, the overall sales business exceeded the 1.4 billion mark, the export business increased significantly, and the third phase of construction was successfully completed and put into operation. He said that in the face of the ever-changing market environment, Shengshi Baicao hopes that companies from all producing areas will continue to work together to help each other, overcome difficulties together, move forward bravely, and jointly draw a better blueprint.

 

---

 

▲ Yichun Watanabe, executive officer of Japan's Tsumura Raw Medicine and deputy general manager of Shengshi Baicao, made a statement on China's career outlook.

 

Yoshiharu Watanabe, executive officer of Japan's Tsumura Raw Medicine and deputy general manager of Shengshi Baicao, explained the vision of China's business, preparation platform and mergers and acquisitions, and explained the basic policies and contents of China's business such as China's big health business and traditional Chinese medicine business.

 

---

 

The head of Japan's Tsuma Pharmaceutical Department gave a detailed video introduction on Tsuma's 2022 final accounts, Japan's business, 2023 performance forecast, 2031 department's vision and department's strategy. He expressed the hope that companies from various producing areas will strengthen their procurement, processing and storage capabilities, help realize the stable supply of raw materials, promote win-win cooperation between the producing areas and Jincun, and jointly contribute to people's health.

 

---

 

▲ Japan's Tsumura Raw Medicine Production Management Department Minister Chao Shan and other history made a description of Japan's Tsumura GACP management policy and related topics

 

Japan's Tsumura raw medicine production and management department minister Chao Shan and other history, the GACP management policy is introduced, and the correct use of pesticides, the correct raw medicine production history information, farmers specific authenticity of the three topics made a detailed description.

 

---

 

Kumasawa Hiroaki, head of the Pollution Countermeasures Department of the Cultivation Technology Development Department of Japan's Tsumura Pharmacokinetics Department, explained the external pollution of the Pharmacokinetics online. The main causes of external pollution, the risks and countermeasures of external pollution of crude drugs, as well as the contents of future, corresponding and strengthening are explained in detail, and the specific corresponding points in the actual operation of Jincun Pollution Countermeasures Section are shared.

 

---

 

▲ Zhang Nai, Minister of Shengshi Baicao Planting Management Department, made GACP management report

 

▲ Zhang Xu, Minister of Shengshi Baicao Quality Management Department, Made 2022 Raw Drug Quality Report

 

▲ Yao Xionghui, Minister of Shengshi Baicao Purchasing Department, made a business report

 

Shengshi Baicao Planting Management Department, Quality Control Department, and Purchasing Department ministers respectively report to the conference and conduct special training on related professional issues.

 

---

 

▲ On-site communication on behalf of the company of origin

 

During the exchange and discussion session, the origin company shared its experience on long-term agreements, medicinal material planting trends, and planting methods.

 

---

 

Yao Ling, Deputy General Manager of Shenzhen Jincun

 

At the meeting, Yao Ling, deputy general manager of Shenzhen Jincun, congratulated Shengshi Baicao on its achievements in 2022, and expressed gratitude to the production company that has been supporting and helping Shenzhen Jincun, and hopes to continue to work together with the production company to achieve better goals.

 

---

 

▲ Li Gang, General Manager of Shengshi Baicao, made a concluding speech

 

At the end of the meeting, Li Gang, general manager of Shengshi Baicao, made a concluding speech. Mr. Li said that in the face of the impact of the epidemic, Shengshi Baicao has successfully completed the set goals and made considerable progress and development. The achievement cannot be achieved without the care and support of the companies in various producing areas. Li always expressed his gratitude to the companies in various producing areas that supported and helped Shengshi Baicao.

 

Mr. Li pointed out that it is necessary to strengthen close cooperation with companies in various producing areas, improve the rigor of work, and ensure timely and sufficient delivery. He stressed: under the guidance of national policies, we should raise our awareness of danger in times of peace, and constantly consolidate the foundation for the production of medicinal materials under the condition of avoiding competing with grain for land, so as to ensure the safety of the production of traditional Chinese medicine. At the same time, Mr. Li expressed the hope that companies from all producing areas will jointly promote the processing of fresh products, give full play to their advantages and characteristics, and contribute to the intellectualization of the Chinese herbal medicine industry in the later period.